Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Abbvie Biotechnology Ltd.
483
•Abbvie Biotechnology Ltd.

FDA 483 - Abbvie Biotechnology Ltd.

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Abbvie Biotechnology LTD in Barceloneta, Puerto Rico, revealed significant deficiencies in quality control systems. The firm failed to adequately investigate and document consumer complaints for its Humira product, and laboratory investigations lacked sufficient supporting evidence. Additionally, procedures for inspecting raw materials and syringes were found to be inadequate, potentially impacting product quality.

Company
Abbvie Biotechnology Ltd.
Product Type
Drugs
Office
Division of Human and Animal Food Operations - East IV
Person
  • Noreen Muniz (Investigator)
Open in Dashboard

ID · b841e8d1-f95e-4ef1-bf9f-48c8f728cd44

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.